Literature DB >> 3624510

Psychiatric side effects from topical ocular timolol, a beta-adrenergic blocker.

J H Shore, F T Fraunfelder, S M Meyer.   

Abstract

Neuropsychiatric side effects have been reported with various systemic betablockers. Data submitted to the National Registry of Drug-Induced Ocular Side Effects appear to indicate similar adverse reactions secondary to topical ophthalmic timolol. One hundred sixty-three of 369 central nervous system cases (44%) reported depression, psychosis, confusion, and hallucinations following topical ophthalmic timolol administration. The psychiatric community should be aware that sudden changes in mental status or onset of common psychiatric conditions, such as depression, may be due to topical ocular timolol. Withdrawal of the drug usually results in disappearance of these effects in 1 to 7 days.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3624510

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


  10 in total

Review 1.  Therapeutic uses of beta-adrenoceptor blocking drugs in the central nervous system in man.

Authors:  P Turner
Journal:  Postgrad Med J       Date:  1989-01       Impact factor: 2.401

Review 2.  Neuropsychiatric Adverse Events from Topical Ophthalmic Timolol.

Authors:  Nevio Cimolai
Journal:  Clin Med Res       Date:  2019-08-28

Review 3.  New developments in the drug treatment of glaucoma.

Authors:  L M Hurvitz; P L Kaufman; A L Robin; R N Weinreb; K Crawford; B Shaw
Journal:  Drugs       Date:  1991-04       Impact factor: 9.546

Review 4.  Systemic adverse effects of topical ophthalmic agents. Implications for older patients.

Authors:  J P Diamond
Journal:  Drugs Aging       Date:  1997-11       Impact factor: 3.923

Review 5.  Systemic and local tolerability of ophthalmic drug formulations. An update.

Authors:  F C Hugues; C Le Jeunne
Journal:  Drug Saf       Date:  1993-05       Impact factor: 5.606

Review 6.  Drug-induced depression in the aged. What can be done?

Authors:  L Ganzini; J R Walsh; S B Millar
Journal:  Drugs Aging       Date:  1993 Mar-Apr       Impact factor: 3.923

7.  Psychiatric side effects of medications prescribed in internal medicine.

Authors:  Rodrigo Casagrande Tango
Journal:  Dialogues Clin Neurosci       Date:  2003-06       Impact factor: 5.986

8.  The association between glaucoma and risk of depression: a nationwide population-based cohort study.

Authors:  Yu-Yen Chen; Yun-Ju Lai; Jen-Pang Wang; Ying-Cheng Shen; Chun-Yuan Wang; Hsin-Hua Chen; Hsiao-Yun Hu; Pesus Chou
Journal:  BMC Ophthalmol       Date:  2018-06-22       Impact factor: 2.209

9.  Prevalence of depression and anxiety among participants with glaucoma in a population-based cohort study: The Gutenberg Health Study.

Authors:  J Rezapour; S Nickels; A K Schuster; M Michal; T Münzel; P S Wild; I Schmidtmann; K Lackner; A Schulz; N Pfeiffer; M E Beutel
Journal:  BMC Ophthalmol       Date:  2018-06-28       Impact factor: 2.209

10.  From Eye Drops to ICU, a Case Report of Three Side Effects of Ophthalmic Timolol Maleate in the Same Patient.

Authors:  Muhammad Asim Rana; Ahmed Fouad Mady; Basheer Abdel Rehman; Abdulrahman Alharthy; Basim Huwait; Asim Riaz; Waleed Tharwat Aletreby
Journal:  Case Rep Crit Care       Date:  2015-08-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.